Navigation Links
Depomed To Report Second Quarter Fiscal Year 2012 Financial Results On Thursday, August 2, 2012
Date:7/30/2012

MENLO PARK, Calif., July 30, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release second quarter fiscal year 2012 financial results after the market closes on Thursday, August 2, 2012. The company will host a conference call beginning at 5:00 pm Eastern time, 2:00 pm California time to discuss its results.

Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on the investor relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed
Depomed, Inc. is a specialty pharmaceutical company with three approved and marketed products. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN). Zipsor ® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of mild to moderate acute pain in adults. Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is commercialized by Santarus, Inc. in the United States. Depomed formulates its products and product candidates with its proven, proprietary Acuform® drug delivery technology, which is designed to improve existing oral medications, allowing for extended release of medications to the upper gastrointestinal tract when dosed with food. Additional information about Depomed may be found on its website, www.depomed.com.

CONTACT:
August J. Moretti  
Depom
'/>"/>

SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
2. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
3. Depomed To Present At Jefferies 2012 Global Health Care Conference
4. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
5. GP Strategies to Report Second Quarter 2012 Results on August 2, 2012
6. Solta Medical Reports Second Quarter Results
7. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
8. Rochester Medical Reports Third Quarter Results
9. Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2013
10. Huntzinger Management Group, Inc., (HMG) Reporting Significant Growth in 2012
11. Hill-Rom Reports Fiscal Third Quarter Results; Announces Aspen Surgical Acquisition; Lowers Full Year Financial Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that the Company will present at the ... 2013 at the Le Parker Meridian hotel, 119 W. 56 ... . The presentation is scheduled to begin at 2:15 p.m. ... Heska Heska Corporation (NASDAQ: HSKA - ...
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World markets ... with the latest trends and events, companies now ... predict where an industry is headed next, so ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... market research publisher GlobalData, offer decision makers and ...
(Date:5/22/2013)... Calif. , May 22, 2013   Accuray ... that its management is scheduled to present at the ... York on Thursday, June 6, 2013 at ... webcast of the presentation will be available online from ... http://www.accuray.com/investors . The webcast replay of the ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4
... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- Sosei ... the,successful completion of a study of its ... for the treatment of cancer,breakthrough pain. , ... centre, open-label,single dose, cross-over, randomised study of ...
... /PRNewswire/ -- A three-year,follow-up subset analysis presented today ... that the CYPHER(R),Sirolimus-eluting Coronary Stent had results comparable ... and better outcomes,than bare metal stents (BMS) in ... arteries. , The CYPHER(R) Stent results in the ...
Cached Medicine Technology:Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 2Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 4
(Date:5/23/2013)... (PRWEB) May 23, 2013 On May 23, ... research and advocacy, commends Salem High School senior Max Merget ... cancer. , According to a Patch.com article, Max ... with anaplastic ependymoma -- a large malignant tumor in the ... He underwent surgery but the tumor came back a year ...
(Date:5/23/2013)... To help members more easily ... pleased to announce integration of its advanced ... new upgrade automatically transfers real-time step data onto ... their company’s team standings, view progress on rewards, ... , Walkingspree also offers an integrated nutritional module ...
(Date:5/23/2013)... South Carolina (PRWEB) May 23, 2013 ... anniversary being in practice. For 25 years, Jeff ... honest legal advice with a focus on personal ... years having worked for insurance companies, he offers clients ... how insurance companies operate, which enables him better serve ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Canadian ... its Max! Healthy Vending Machines, and that's in sync ... report prepared for the Canada Organic Trade Association (COTA). ... organic food and beverages each year. This makes the ... the world. , As a Canadian leader in ...
(Date:5/23/2013)... Portland, Oregon (PRWEB) May 23, 2013 Better ... touches as it prepares to launch its one of ... Final training of management staff will be completed May 29th, ... Chris and Heather Richardson completed on site training in Portland ... the 29th to complete operational training. , "It really is ...
Breaking Medicine News(10 mins):Health News:Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3Health News:Ezell Law Firm Celebrates 25 Years in Practice 2Health News:Max! Healthy Vending Machines in Tune with Burgeoning Organic Foods Market 2Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2
... Alexandria, VA - The 2011 Annual Meeting & OTO ... and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ... convene September 11-14, 2011 in San Francisco, CA. ... and several hundred instruction course hours for attendees, the ...
... effective in helping patients manage their Type 2 diabetes using ... of Maryland School of Medicine researchers. The study is being ... Care . The study, one of the first to scientifically ... blood sugar control the amount of hemoglobin A1c in ...
... Reporter , FRIDAY, July 29 (HealthDay News) -- The ... it uses to approve and regulate "moderate-risk" medical devices ... a highly anticipated federal report released Friday. Instead, ... process that ensures the devices go through more rigorous ...
... College of Radiology and society of Breast Imaging, two top ... issued a statement on a controversial study published in the ... which claimed that there is no evidence that mammography served ... countries where screening has been implemented. , , The ACR ...
... -- The brains of two of four former Canadian ... associated with concussions, say researchers with the Canadian Sports ... (of the Toronto Argonauts and Hamilton Tiger-Cats) and Jay ... encephalopathy (CTE). Both players suffered repeated concussions during their ...
... July 29 (HealthDay News) -- Excluding children from discussions about ... a new study finds. Parents and medical professionals need ... them in decisions, said the researchers from Dublin, Ireland. ... to 18, at three hospitals and found that the kids ...
Cached Medicine News:Health News:World's largest meeting of ear, nose and throat doctors 2Health News:UM School of Medicine finds that mobile phone technology helps patients manage diabetes 2Health News:Report Urges New Review System for Medical Devices 2Health News:Report Urges New Review System for Medical Devices 3Health News:Concussion Project Finds Disease in Two Autopsied Brains 2Health News:Study Finds Kids Want More Info About Their Hospital Care 2
... Codman Sofwire Cable System, ... fixation including sublaminar interspinous ... facial surgery, sternotomy closure. ... and a complete set ...
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
... Inductive demineralized bone matrix ... and cancellous chips will be ... bone matrix particle size is ... chip particle size is 1 ...
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue....
Medicine Products: